MUFG Securities Americas’s Vertex Pharmaceuticals VRTX Stock Holding History

MUFG Securities Americas’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.8M	Buy	7,645 +617	+9%	+$273K	0.2%	89
2026 Q1	$3.14M	Buy	7,028 +193	+3%	+$90K	0.2%	92
2025 Q4	$3.1M	Sell	6,835 -79	-1%	-$34.1K	0.19%	99
2025 Q3	$2.71M	Buy	6,914 +1,223	+21%	+$511K	0.17%	106
2025 Q2	$2.53M	Buy	5,691 +1,146	+25%	+$528K	0.22%	89
2025 Q1	$2.2M	Buy	4,545 +743	+20%	+$346K	0.26%	81
2024 Q4	$1.53M	Buy	+3,802	New	+$1.76M	0.19%	98

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MUFG Securities Americas's VRTX Position: Q2 2026 in Review

MUFG Securities Americas increased its Vertex Pharmaceuticals (VRTX) stake by 8.8% in Q2 2026, buying an estimated $273K and bringing the position to 7,645 shares worth $3.8M. The position accounts for 0.2% of the portfolio, ranked #89.

MUFG Securities Americas first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

MUFG Securities Americas held 7,645 shares of Vertex Pharmaceuticals worth $3.8M as of Q2 2026.
MUFG Securities Americas bought 617 Vertex Pharmaceuticals shares in Q2 2026, an estimated $273K.
Vertex Pharmaceuticals made up 0.2% of MUFG Securities Americas's portfolio in Q2 2026, its #89 holding.
MUFG Securities Americas first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.